NCT05233878View on ClinicalTrials.gov

Prognostic's Factors of Head and Neck Paragangliomas Evolution

Active, not recruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Paraganglioma
Interventions
OTHER

Characterization of a population with cervical paragangliomas

Characterization of a population with sporadic or genetically predisposed cervical paragangliomas in order to evaluate : the initial presentation of the PGL, patients management and patients outcome

Trial Locations (1)

69500

Fédération d'endocrinologie Hôpital Cardiologique/Groupement Hospitalier Est, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER